Announcing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...

What if cutting off a tumor’s fat supply could also rally the immune system to join the fight? Liver cancer fueled by fatty liver disease is on the rise, and with low survival rates, new treatment ...

FAS, fatty acid synthase; FATP, fatty acid transporter protein; GPCR, G protein-coupled receptor; LPC, lysophosphatidylcholine; LXR, liver X receptor; PPARγ, peroxisome proliferator-activated receptor ...

It is hardly news that tumor cells, compared to healthy ones, show metabolic reprogramming that accelerates the production of energy and biosynthetic precursors to support rapid growth. What is newly ...

Metabolic reprogramming in cancer involves glycolytic enzymes acquiring noncanonical functions and acting as protein kinases, which contribute to tumor progression and present new therapeutic ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal ...